Skip to content

To Evaluate and study analgesic effect of fentanyl as an additive to intrathecal hyperbaric ropivacaine for lower limb surgery

Evaluation of the analgesic effect of fentanyl as an additive to intrathecal hyperbaric ropivacaine for lower limb surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052455
Enrollment
100
Registered
2023-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine with fentanyl: 3ml of 0.75%ropivacaine with 0.5ml of fentanyl intrathecally while giving spinal anaesthesia to assess total duration of analgesia till 24 hours after surgery

Sponsors

Dr. Sarvjeet Kaur
Lead Sponsor
Dr Amanjot Singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for elective lower limb surgeries under spinal anaesthesia. 2.Patients aged between 18-60 years of either gender, giving valid informed and written consent. 3.Patients belonging to American Society of Anaesthesiology (ASA) grade I and II.

Exclusion criteria

Exclusion criteria: 1.Patient with Known allergy to drugs used in study 2.Any contraindications to spinal anaesthesia 3.Coagulopathy and bleeding diathesis 4.Patients diagnosed with psychiatric ailments 5.History of drug/substance abuse 6.Patients on anti arrhythmic treatment BMI >35 kg/m2

Design outcomes

Primary

MeasureTime frame
1.To study duration of analgesia with intrathecal ropivacaine in lower limb surgery. 2.To study duration of analgesia with intrathecal ropivacaine and fentanyl in lower limb surgery. 3.To compare duration of analgesia with intrathecal ropivacaine versus intrathecal ropivacaine with fentanyl in lower limb surgery. Timepoint: Outcome will be assessed at the end of study that is 12 months

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactAashima Mahajan

GGSMCH FARIDKOT

drsarvjeetk@gmail.com9915680508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026